New Jersey bills · 2026-2027 Regular Session
New Jersey S 446
Requires health benefits plans to cover abuse-deterrent opioid analgesic drug products.
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Became law
Sponsors
- Stack, Brian P. (Democratic)
Summary
No official summary is available for this bill.
Latest action(Jan 13, 2026): Introduced in the Senate, Referred to Senate Commerce Committee
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Jan 13, 2026 · Senate
Introduced in the Senate, Referred to Senate Commerce Committee